FIIs May Return to India: IT, BFSI, Pharma in Focus, Says Nuvama's Shiv Sehgal

Market
C
CNBC TV18•10-02-2026, 14:05
FIIs May Return to India: IT, BFSI, Pharma in Focus, Says Nuvama's Shiv Sehgal
- •Foreign investor sentiment on India may be turning after a prolonged period of outflows, according to Shiv Sehgal of Nuvama Capital Markets.
- •Sehgal suggests that FIIs might start 'nibbling back' into the Indian market, citing the mood at the 21st Nuvama India Conference.
- •Recent developments like trade deals, improving credit growth, and positive channel checks indicate India is moving out of a consolidation phase.
- •IT sector, despite current weakness, shows resilience and adaptability, with potential for recovery in the next 2-3 quarters.
- •BFSI and pharma/healthcare sectors are highlighted as key themes, supported by strong bank balance sheets, US generics stability, and China-plus-one shift.
✦
More like this
Loading more articles...





